Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
The global Albumin (as Excipient) market is projected to grow from US$ 4627.7 million in 2024 to US$ 6601.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period.
The industry's leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019.
By region, Asia-Pacific is the largest consumption market of Albumin (as Excipient), with its sales volume at 70.83%.
Report Covers:
This report presents an overview of global market for Albumin (as Excipient), sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Albumin (as Excipient), also provides the sales of main regions and countries. Highlights of the upcoming market potential for Albumin (as Excipient), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Albumin (as Excipient) sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Albumin (as Excipient) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Albumin (as Excipient) sales, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
HiMedia
Segment by Type
Human Serum Albumin
Recombinant Albumin
Segment by Application
Cell Culture Media
Medical Supplements
Therapeutics
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Albumin (as Excipient) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Albumin (as Excipient) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Albumin (as Excipient) sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Albumin (as Excipient) Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Albumin (as Excipient) 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Human Serum Albumin
1.2.3 Recombinant Albumin
1.3 麻豆原创 by Application
1.3.1 Global Albumin (as Excipient) 麻豆原创 Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Cell Culture Media
1.3.3 Medical Supplements
1.3.4 Therapeutics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Albumin (as Excipient) Sales Estimates and Forecasts 2019-2030
2.2 Global Albumin (as Excipient) Revenue by Region
2.2.1 Global Albumin (as Excipient) Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Albumin (as Excipient) Revenue by Region (2019-2024)
2.2.3 Global Albumin (as Excipient) Revenue by Region (2025-2030)
2.2.4 Global Albumin (as Excipient) Revenue 麻豆原创 Share by Region (2019-2030)
2.3 Global Albumin (as Excipient) Sales Estimates and Forecasts 2019-2030
2.4 Global Albumin (as Excipient) Sales by Region
2.4.1 Global Albumin (as Excipient) Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Albumin (as Excipient) Sales by Region (2019-2024)
2.4.3 Global Albumin (as Excipient) Sales by Region (2025-2030)
2.4.4 Global Albumin (as Excipient) Sales 麻豆原创 Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Albumin (as Excipient) Sales by Manufacturers
3.1.1 Global Albumin (as Excipient) Sales by Manufacturers (2019-2024)
3.1.2 Global Albumin (as Excipient) Sales 麻豆原创 Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Albumin (as Excipient) in 2023
3.2 Global Albumin (as Excipient) Revenue by Manufacturers
3.2.1 Global Albumin (as Excipient) Revenue by Manufacturers (2019-2024)
3.2.2 Global Albumin (as Excipient) Revenue 麻豆原创 Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Albumin (as Excipient) Revenue in 2023
3.3 Global Key Players of Albumin (as Excipient), Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Albumin (as Excipient) Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers 麻豆原创 Concentration Ratio (CR5 and HHI)
3.5.2 Global Albumin (as Excipient) 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Albumin (as Excipient), Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Albumin (as Excipient), Product Offered and Application
3.8 Global Key Manufacturers of Albumin (as Excipient), Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 麻豆原创 Size by Type
4.1 Global Albumin (as Excipient) Sales by Type
4.1.1 Global Albumin (as Excipient) Historical Sales by Type (2019-2024)
4.1.2 Global Albumin (as Excipient) Forecasted Sales by Type (2025-2030)
4.1.3 Global Albumin (as Excipient) Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Albumin (as Excipient) Revenue by Type
4.2.1 Global Albumin (as Excipient) Historical Revenue by Type (2019-2024)
4.2.2 Global Albumin (as Excipient) Forecasted Revenue by Type (2025-2030)
4.2.3 Global Albumin (as Excipient) Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Albumin (as Excipient) Price by Type
4.3.1 Global Albumin (as Excipient) Price by Type (2019-2024)
4.3.2 Global Albumin (as Excipient) Price Forecast by Type (2025-2030)
5 麻豆原创 Size by Application
5.1 Global Albumin (as Excipient) Sales by Application
5.1.1 Global Albumin (as Excipient) Historical Sales by Application (2019-2024)
5.1.2 Global Albumin (as Excipient) Forecasted Sales by Application (2025-2030)
5.1.3 Global Albumin (as Excipient) Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Albumin (as Excipient) Revenue by Application
5.2.1 Global Albumin (as Excipient) Historical Revenue by Application (2019-2024)
5.2.2 Global Albumin (as Excipient) Forecasted Revenue by Application (2025-2030)
5.2.3 Global Albumin (as Excipient) Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Albumin (as Excipient) Price by Application
5.3.1 Global Albumin (as Excipient) Price by Application (2019-2024)
5.3.2 Global Albumin (as Excipient) Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Albumin (as Excipient) 麻豆原创 Size by Type
6.1.1 US & Canada Albumin (as Excipient) Sales by Type (2019-2030)
6.1.2 US & Canada Albumin (as Excipient) Revenue by Type (2019-2030)
6.2 US & Canada Albumin (as Excipient) 麻豆原创 Size by Application
6.2.1 US & Canada Albumin (as Excipient) Sales by Application (2019-2030)
6.2.2 US & Canada Albumin (as Excipient) Revenue by Application (2019-2030)
6.3 US & Canada Albumin (as Excipient) 麻豆原创 Size by Country
6.3.1 US & Canada Albumin (as Excipient) Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Albumin (as Excipient) Sales by Country (2019-2030)
6.3.3 US & Canada Albumin (as Excipient) Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Albumin (as Excipient) 麻豆原创 Size by Type
7.1.1 Europe Albumin (as Excipient) Sales by Type (2019-2030)
7.1.2 Europe Albumin (as Excipient) Revenue by Type (2019-2030)
7.2 Europe Albumin (as Excipient) 麻豆原创 Size by Application
7.2.1 Europe Albumin (as Excipient) Sales by Application (2019-2030)
7.2.2 Europe Albumin (as Excipient) Revenue by Application (2019-2030)
7.3 Europe Albumin (as Excipient) 麻豆原创 Size by Country
7.3.1 Europe Albumin (as Excipient) Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Albumin (as Excipient) Sales by Country (2019-2030)
7.3.3 Europe Albumin (as Excipient) Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Albumin (as Excipient) 麻豆原创 Size
8.1.1 China Albumin (as Excipient) Sales (2019-2030)
8.1.2 China Albumin (as Excipient) Revenue (2019-2030)
8.2 China Albumin (as Excipient) 麻豆原创 Size by Application
8.2.1 China Albumin (as Excipient) Sales by Application (2019-2030)
8.2.2 China Albumin (as Excipient) Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Albumin (as Excipient) 麻豆原创 Size by Type
9.1.1 Asia Albumin (as Excipient) Sales by Type (2019-2030)
9.1.2 Asia Albumin (as Excipient) Revenue by Type (2019-2030)
9.2 Asia Albumin (as Excipient) 麻豆原创 Size by Application
9.2.1 Asia Albumin (as Excipient) Sales by Application (2019-2030)
9.2.2 Asia Albumin (as Excipient) Revenue by Application (2019-2030)
9.3 Asia Albumin (as Excipient) Sales by Region
9.3.1 Asia Albumin (as Excipient) Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Albumin (as Excipient) Revenue by Region (2019-2030)
9.3.3 Asia Albumin (as Excipient) Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Albumin (as Excipient) 麻豆原创 Size by Type
10.1.1 Middle East, Africa and Latin America Albumin (as Excipient) Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Albumin (as Excipient) Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Albumin (as Excipient) 麻豆原创 Size by Application
10.2.1 Middle East, Africa and Latin America Albumin (as Excipient) Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Albumin (as Excipient) Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Albumin (as Excipient) Sales by Country
10.3.1 Middle East, Africa and Latin America Albumin (as Excipient) Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Albumin (as Excipient) Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Albumin (as Excipient) Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 CSL
11.1.1 CSL Company Information
11.1.2 CSL Overview
11.1.3 CSL Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 CSL Albumin (as Excipient) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CSL Recent Developments
11.2 Grifols
11.2.1 Grifols Company Information
11.2.2 Grifols Overview
11.2.3 Grifols Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Grifols Albumin (as Excipient) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Grifols Recent Developments
11.3 Takeda
11.3.1 Takeda Company Information
11.3.2 Takeda Overview
11.3.3 Takeda Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Takeda Albumin (as Excipient) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Takeda Recent Developments
11.4 Octapharma
11.4.1 Octapharma Company Information
11.4.2 Octapharma Overview
11.4.3 Octapharma Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Octapharma Albumin (as Excipient) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Octapharma Recent Developments
11.5 Hualan Bio
11.5.1 Hualan Bio Company Information
11.5.2 Hualan Bio Overview
11.5.3 Hualan Bio Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Hualan Bio Albumin (as Excipient) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Hualan Bio Recent Developments
11.6 CBPO
11.6.1 CBPO Company Information
11.6.2 CBPO Overview
11.6.3 CBPO Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 CBPO Albumin (as Excipient) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CBPO Recent Developments
11.7 Shanghai RAAS
11.7.1 Shanghai RAAS Company Information
11.7.2 Shanghai RAAS Overview
11.7.3 Shanghai RAAS Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Shanghai RAAS Albumin (as Excipient) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shanghai RAAS Recent Developments
11.8 Kedrion
11.8.1 Kedrion Company Information
11.8.2 Kedrion Overview
11.8.3 Kedrion Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Kedrion Albumin (as Excipient) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Kedrion Recent Developments
11.9 LFB Group
11.9.1 LFB Group Company Information
11.9.2 LFB Group Overview
11.9.3 LFB Group Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 LFB Group Albumin (as Excipient) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 LFB Group Recent Developments
11.10 Albumedix
11.10.1 Albumedix Company Information
11.10.2 Albumedix Overview
11.10.3 Albumedix Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Albumedix Albumin (as Excipient) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Albumedix Recent Developments
11.11 Biotest
11.11.1 Biotest Company Information
11.11.2 Biotest Overview
11.11.3 Biotest Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Biotest Albumin (as Excipient) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Biotest Recent Developments
11.12 Merck
11.12.1 Merck Company Information
11.12.2 Merck Overview
11.12.3 Merck Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Merck Albumin (as Excipient) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Merck Recent Developments
11.13 Ventria (InVitria)
11.13.1 Ventria (InVitria) Company Information
11.13.2 Ventria (InVitria) Overview
11.13.3 Ventria (InVitria) Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Ventria (InVitria) Albumin (as Excipient) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Ventria (InVitria) Recent Developments
11.14 HiMedia
11.14.1 HiMedia Company Information
11.14.2 HiMedia Overview
11.14.3 HiMedia Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 HiMedia Albumin (as Excipient) Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 HiMedia Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Albumin (as Excipient) Industry Chain Analysis
12.2 Albumin (as Excipient) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Albumin (as Excipient) Production Mode & Process
12.4 Albumin (as Excipient) Sales and 麻豆原创ing
12.4.1 Albumin (as Excipient) Sales Channels
12.4.2 Albumin (as Excipient) Distributors
12.5 Albumin (as Excipient) Customers
13 麻豆原创 Dynamics
13.1 Albumin (as Excipient) Industry Trends
13.2 Albumin (as Excipient) 麻豆原创 Drivers
13.3 Albumin (as Excipient) 麻豆原创 Challenges
13.4 Albumin (as Excipient) 麻豆原创 Restraints
14 Key Findings in The Global Albumin (as Excipient) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
HiMedia
听
听
*If Applicable.